Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D5X9 | ISIN: CA64119M1059 | Ticker-Symbol: PF0
Frankfurt
26.04.24
08:16 Uhr
0,186 Euro
+0,007
+3,91 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NETRAMARK HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
NETRAMARK HOLDINGS INC 5-Tage-Chart

Aktuelle News zur NETRAMARK Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.04.Netramark Holdings Inc: Netramark releases data on NetraAI clinical trial1
10.04.Netramark's Ai-based Clinical Solution Identifies Novel Lung And Colon Cancer Biomarkers And Patient Subpopulations1
05.04.Netramark Holdings Inc: Netramark shareholders approve all matters at AGM1
05.04.Netramark Announces Shareholder Meeting Results 1
04.04.Netramark Holdings Inc: Netramark appoints Huntsman to advisory board1
04.04.Pharmaceutical Industry Veteran Joins Netramark Advisory Board2
02.04.Netramark Holdings Inc: Netramark talks NetraAI Lab rollout, signed contracts1
02.04.Netramark Provides Business Update And Highlights Progress1
12.03.Netramark Holdings Inc: Netramark signs NetraAI contract with pharma company1
12.03.Netramark Signs Contract With Pharmaceutical Company To Deliver Clinical Trial Insights Regarding Efficacy And Placebo Response1
11.03.Netramark Holdings Inc: Netramark Holdings finds Parkinson's subtypes1
11.03.Netramark's Ai-based Clinical Solution Identifies Parkinson's Disease Subtypes Linked By Mitochondrial, Microbiome And Immune Signaling1
29.02.Netramark To Present New Data Highlighting The Utility Of It's Ai-based Clinical Solution In Identifying Parkinson's Disease Associated Biomarkers At Ad/pd 20241
27.02.Netramark Holdings Inc: Netramark signs fourth contract with biopharm firm1
27.02.Netramark Signs Fourth Contract With Large Biopharmaceutical Company To Enhance Clinical Trial Insights1
26.02.Netramark Holdings Inc: Netramark Holdings presents NetraAI data1
26.02.Netramark's Ai-based Technology Identifies Significant Drivers Of Efficacy And Placebo Responses And Has Potential To Improve Success Rates For Clinical Trials Of Psychiatric Medications1
15.02.Netramark To Present New Data Demonstrating The Power Of Its Ai Based Technology To De-risk Neurology Clinical Trials At Isctm Annual Meeting1
12.02.NetraMark Holdings launches NetraAI Lab1
12.02.Netramark Announces Launch Of The Netra Ai Lab1
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1